Once Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma: High-Risk Cytogenetic Risk Planned Subgroup Analyses from the Phase 3 Boston Study - Richard,S; Chari,A; Delimpasi,S; Simonova,M; Spicka,I; Pour,L; Kryachok,I; Dimopoulos,MA; Pylypenko,H; Auner,HW; Leleu,X; Doronin,VA; et al. (AMER SOC HEMATOLOGY, 2020)